Myrexis

Last updated

Myrexis is a biopharmaceutical company based in Salt Lake City, Utah, USA. It focused on drug development in several areas of medicine, in particular cancer therapy and auto-immune diseases. It was founded in 1999 as a spin-off from Myriad Genetics [1] and was originally known as Myriad Pharmaceuticals. Richard B. Brewer was its CEO from May 2012 until his death in August 2012. [2] [3]

In February 2012 the company announced they had suspended development activity on all of its clinical and preclinical programs and appointed an investment company Stifel Nicolaus Weisel to evaluate strategic alternatives. [4] In November 2012, the board of Myrexis announced that it planned to put the company into liquidation subject to shareholder approval. [5] In January 2013, the board reversed its decision, cancelled the liquidation, declared a special cash distribution to shareholders and appointed Jonathan M. Couchman (chairman of Xselos Holdings) as president and chief executive officer. The remaining members of the board then resigned. [6]

Related Research Articles

Corporate titles or business titles are given to company and organization officials to show what duties and responsibilities they have in the organization. Such titles are used by publicly and privately held for-profit corporations. In addition, many non-profit organizations, educational institutions, partnerships, and sole proprietorships also confer corporate titles.

TMX Group Canadian financial services company

TMX Group Limited is a Canadian financial services company that operates equities, fixed income, derivatives, and energy markets exchanges. The company provides services encompassing listings, trading, clearing, settling and depository facilities, information services as well as technology services for the international financial community.

AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It is perhaps best known for its involvement in developing the Oxford-AstraZeneca COVID-19 vaccine.

Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines and nutritional products. It split off its research-based pharmaceuticals business into AbbVie in 2013.

Bristol Myers Squibb American pharmaceutical company

Bristol Myers Squibb (BMS) is an American multinational pharmaceutical company, headquartered in New York City. BMS is one of the world's largest pharmaceutical companies, and is consistently ranked on the Fortune 500 list of the largest U.S. corporations. As of September 2020, it had the total revenue of $39.3 billion.

Ahold Dutch international retail company

Koninklijke Ahold N.V. was a Dutch international retailer based in Zaandam, Netherlands. It merged with Delhaize Group in 2016 to form Ahold Delhaize.

Aviva British insurance company

Aviva plc is a British multinational insurance company headquartered in London, England. It has about 33 million customers across 16 countries. In the United Kingdom, Aviva is the largest general insurer and a leading life and pensions provider.

Shire plc was a UK-founded Jersey-registered specialty biopharmaceutical company. Originating in the United Kingdom with an operational base in the United States, its brands and products included Vyvanse, Lialda, and Adderall XR. Shire was acquired by Takeda Pharmaceutical Company on 8 January 2019.

Townsquare Media American radio network and media company

Townsquare Media, Inc. is an American radio network and media company based in Purchase, New York. The company started in radio and expanded into digital media toward the end of the 2000s, starting with the acquisition of the MOG Music Network. As of 2019, Townsquare was the third-largest AM–FM operator in the country, owning over 321 radio stations in 67 markets.

Klaus Kleinfeld German businessman

Klaus-Christian Kleinfeld is the former chairman and chief executive officer (CEO) of Arconic. Kleinfeld is former chairman and CEO of Alcoa Inc., and former president and CEO of Siemens AG. Kleinfeld stepped down as chairman and CEO of Arconic on 17 April 2017. In October 2017, he was named director of Saudi Arabia's Neom initiative. It was announced in July 2018 that Kleinfeld would be promoted from director of Neom to advisor of Crown Prince Muhammad bin Salman on 1 August 2018, and that Nadhmi Al-Nasr would succeed him as director of Neom.

Bausch Health Companies Inc. is a multinational specialty pharmaceutical company based in Laval, Quebec, Canada. It develops, manufactures and markets pharmaceutical products and branded generic drugs, primarily for skin diseases, gastrointestinal disorders, eye health and neurology. Bausch Health owns Bausch & Lomb, a supplier of eye health products.

Perrigo Irish tax-registered pharmaceutical

Perrigo Company plc is an American Irish–registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the 6th-largest U.S. corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes.

Ipsen is a French pharmaceutical company headquartered in Paris, France. It is specialized in three therapeutic areas: oncology, neuroscience and rare diseases.

Teva Pharmaceuticals Israeli pharmaceutical company

Teva Pharmaceutical Industries Ltd., also known as Teva Pharmaceuticals, is a global pharmaceutical company with headquarters in Petah Tikva, Israel. It specializes primarily in generic drugs, but other business interests include active pharmaceutical ingredients and, to a lesser extent, proprietary pharmaceuticals. In 2020, Teva Pharmaceuticals was the second largest generic drug manufacturer and the eighteenth largest pharmaceutical company in the world.

AECOM American engineering firm

AECOM is an American multinational engineering firm.

Unibail-Rodamco-Westfield French real estate company

Unibail-Rodamco-Westfield SE is a European commercial real estate company headquartered in Paris, France. Its history originates with the formation of two separate shopping centre operators, Unibail and Rodamco Europe, which merged in 2007 and became a societas Europaea in 2009. The company acquired Australian shopping centre operator Westfield Corporation in June 2018.

PPD, Inc. Contract research organization

Pharmaceutical Product Development (PPD) is a global contract research organization (CRO) providing comprehensive, integrated drug development, laboratory and lifecycle management services.

Ulf Mark Schneider

Ulf Mark Schneider is a German/American businessman, and the CEO of Nestlé. He is the former CEO of Fresenius, a €28 billion global healthcare group.

David Drummond (businessman) American business executive and lawyer

David Carl Drummond is an American business executive and lawyer. He served as senior vice president (SVP) of corporate development and chief legal officer (CLO) for Alphabet Inc., and, formerly, for its subsidiary, Google. Prior to joining Google, in 2002, Drummond was a partner at law firm Wilson Sonsini Goodrich & Rosati and then chief financial officer of software company SmartForce. Drummond retired from Alphabet on January 31, 2020.

Apricus Biosciences

Apricus Biosciences, Inc. is a San Diego based biopharmaceutical company advancing innovative medicines in urology and rheumatology.

References

  1. Staff (2 July 2009) "Myriad Pharmaceuticals, Inc. Established As An Independent Pharmaceutical Development Company" Pharmaceutical Online, 2 July 2009. Retrieved 26 July 2014
  2. "Richard Brewer". San Francisco Chronicle . 20 August 2012. Retrieved 25 August 2012.
  3. "Myrexis Announces Death of Chief Executive Officer Richard B. Brewer, Trailblazing Biotechnology Industry Veteran and Patient Advocate". Myrexis. Archived from the original on November 5, 2012. Retrieved 15 August 2012.
  4. Staff. "MYRX.PK - Myrexis Inc Profile | Reuters". Reuters. Retrieved 2021-02-05.[ dead link ]
  5. Tadena, Nathalie, "Myrexis Board Approves Plan to Liquidate Assets, Dissolve Company", The Wall Street Journal, 9 November 2012. Retrieved 20 January 2013 [ dead link ]
  6. Myrexis Inc press release:"Myrexis, Inc. Announces the Cancellation of Its Upcoming Shareholder Meeting", carried by Bloomberg, 23 January 2013. Retrieved 26 July 2014